 | • レポートコード：MRC-IM30008 • 出版社/出版日：IMARC / 2022年10月 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥359,856 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥647,856 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年に67億ドルであった世界の変形性関節症治療薬市場規模が、2022年から2027年の間にCAGR 8.5％で成長し、2027年までに109億ドルに達すると予測しています。本調査レポートでは、変形性関節症治療薬の世界市場について総合的に調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、部位別（膝、腰、手、脊椎、その他）分析、薬剤種類別（非ステロイド性抗炎症薬、鎮痛剤、コルチコステロイド、その他）分析、投与経路別（非経口薬、局所薬、経口薬）分析、流通チャネル別（病院、専門クリニック、医療機関、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目をまとめています。なお、本書に掲載されている企業情報には、Abbott Laboratories, Anika Therapeutics Inc., Bayer Aktiengesellschaft, Eli Lilly and Company, Flexion Therapeutics Inc., GlaxoSmithKline Plc, Horizon Therapeutics Plc, Johnson & Johnson Inc., Pfizer Inc., Sanofi S.A.などが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の変形性関節症治療薬市場規模：部位別 - 膝の市場規模 - 腰の市場規模 - 手の市場規模 - 脊椎の市場規模 - その他部位の市場規模 ・世界の変形性関節症治療薬市場規模：薬剤種類別 - 非ステロイド性抗炎症薬の市場規模 - 鎮痛剤の市場規模 - コルチコステロイドの市場規模 - その他薬剤の市場規模 ・世界の変形性関節症治療薬市場規模：投与経路別 - 非経口薬の市場規模 - 局所薬の市場規模 - 経口薬の市場規模 ・世界の変形性関節症治療薬市場規模：流通チャネル別 - 病院チャネルの市場規模 - 専門クリニックチャネルの市場規模 - 医療機関チャネルの市場規模 - その他流通チャネルの市場規模 ・世界の変形性関節症治療薬市場規模：地域別 - 北米の変形性関節症治療薬市場規模 - アジアの変形性関節症治療薬市場規模 - 欧州の変形性関節症治療薬市場規模 - 中南米の変形性関節症治療薬市場規模 - 中東・アフリカの変形性関節症治療薬市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global osteoarthritis therapeutics market size reached US$ 6.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2027, exhibiting a growth rate (CAGR) of 8.5% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Osteoarthritis (OA) is a heterogeneous condition characterized by progressive degeneration of cartilage in joints of the knees, hips, hands, feet, spine, shoulders and neck. OA generally leads to stiffness, swelling, tenderness, persistent pain, loss of flexibility, grating sensation, bone spurs and sleep disturbances. It can be diagnosed using physical examination, X-ray, arthroscopy, joint fluid analysis, blood tests and magnetic resonance imaging (MRI) scan. Various medications and surgical procedures are prescribed as per the different results to alleviate the signs and symptoms of the disease. Currently, alternative medicines, physical therapies and supportive devices are available in the market to relieve pain and improve joint function.
Global Osteoarthritis Therapeutics Market Trends and Drivers:
Sedentary lifestyles, unhealthy dietary patterns and the rising prevalence of obesity and blood sugar are increasing the risk of developing OA among individuals. This, in confluence with the growing geriatric population, which is more susceptible to such ailments, represents one of the key factors impelling the osteoarthritis therapeutics market growth. Apart from this, the easy access to MRI scans is acting as another major growth-inducing factor. Additionally, the development of imaging biomarkers based on radiographic features, coupled with the introduction of analgesic drugs, is contributing to the market growth. Furthermore, rising investments in the research and development (R&D) activities to launch new diagnostics and biomarkers, along with the increasing expenditures on improving healthcare infrastructure, is also driving the market. For instance, disease-modifying drugs are under development, which focus on proinflammatory cytokines for treating cartilage breakdown.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global osteoarthritis therapeutics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on anatomy type, drug type, route of administration and distribution channel.
Breakup by Anatomy Type:
Knee
Hip
Hand
Spine
Others
Breakup by Drug Type:
Nonsteroidal Anti-Inflammatory Drugs
Analgesics
Corticosteroids
Others
Breakup by Route of Administration:
Parenteral
Topical
Oral
Breakup by Distribution Channel:
Hospitals
Specialty Clinics
Medical Institutions
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Anika Therapeutics Inc., Bayer Aktiengesellschaft, Eli Lilly and Company, Flexion Therapeutics Inc., GlaxoSmithKline Plc, Horizon Therapeutics Plc, Johnson & Johnson Inc., Pfizer Inc. and Sanofi S.A.
Key Questions Answered in This Report:
How has the global osteoarthritis therapeutics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global osteoarthritis therapeutics market?
What are the key regional markets?
What is the breakup of the market based on the anatomy type?
What is the breakup of the market based on the drug type?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global osteoarthritis therapeutics market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Osteoarthritis Therapeutics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Anatomy Type
6.1 Knee
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Hip
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Hand
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Spine
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Drug Type
7.1 Nonsteroidal Anti-Inflammatory Drugs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Analgesics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Corticosteroids
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Route of Administration
8.1 Parenteral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Topical
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Oral
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Specialty Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Medical Institutions
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Anika Therapeutics Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bayer Aktiengesellschaft
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Eli Lilly and Company
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Flexion Therapeutics Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.6 GlaxoSmithKline Plc
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Horizon Therapeutics Plc
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Johnson & Johnson Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Pfizer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sanofi S.A
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
Figure 2: Global: Osteoarthritis Therapeutics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Osteoarthritis Therapeutics Market: Breakup by Anatomy Type (in %), 2021
Figure 4: Global: Osteoarthritis Therapeutics Market: Breakup by Drug Type (in %), 2021
Figure 5: Global: Osteoarthritis Therapeutics Market: Breakup by Route of Administration (in %), 2021
Figure 6: Global: Osteoarthritis Therapeutics Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Osteoarthritis Therapeutics Market: Breakup by Region (in %), 2021
Figure 8: Global: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 9: Global: Osteoarthritis Therapeutics (Knee) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Osteoarthritis Therapeutics (Knee) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Osteoarthritis Therapeutics (Hip) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12 Global: Osteoarthritis Therapeutics (Hip) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Osteoarthritis Therapeutics (Hand) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Osteoarthritis Therapeutics (Hand) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Osteoarthritis Therapeutics (Spine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Osteoarthritis Therapeutics (Spine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Osteoarthritis Therapeutics (Other Anatomy Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Osteoarthritis Therapeutics (Other Anatomy Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Osteoarthritis Therapeutics (Nonsteroidal Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Osteoarthritis Therapeutics (Nonsteroidal Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Osteoarthritis Therapeutics (Analgesics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Osteoarthritis Therapeutics (Analgesics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Osteoarthritis Therapeutics (Corticosteroids) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Osteoarthritis Therapeutics (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Osteoarthritis Therapeutics (Other Drug Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Osteoarthritis Therapeutics (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Osteoarthritis Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Osteoarthritis Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Osteoarthritis Therapeutics (Topical) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Osteoarthritis Therapeutics (Topical) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Osteoarthritis Therapeutics (Oral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Osteoarthritis Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Osteoarthritis Therapeutics (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Osteoarthritis Therapeutics (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Osteoarthritis Therapeutics (Specialty Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Osteoarthritis Therapeutics (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Osteoarthritis Therapeutics (Medical Institutions) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Osteoarthritis Therapeutics (Medical Institutions) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Osteoarthritis Therapeutics (Other Distribution Channels) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Osteoarthritis Therapeutics (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: North America: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: North America: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: United States: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: United States: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Canada: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Canada: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Asia Pacific: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Asia Pacific: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: China: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: China: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Japan: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Japan: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: India: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: India: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: South Korea: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: South Korea: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Australia: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Australia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Indonesia: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Indonesia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Europe: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Europe: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Germany: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Germany: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: France: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: France: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: United Kingdom: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: United Kingdom: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Italy: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Italy: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Spain: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Spain: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Russia: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Russia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Latin America: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Latin America: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Brazil: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Brazil: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Mexico: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Mexico: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Middle East and Africa: Osteoarthritis Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Middle East and Africa: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Global: Osteoarthritis Therapeutics Industry: SWOT Analysis
Figure 90: Global: Osteoarthritis Therapeutics Industry: Value Chain Analysis
Figure 91: Global: Osteoarthritis Therapeutics Industry: Porter’s Five Forces Analysis
• 日本語訳：変形性関節症治療薬の世界市場：動向・シェア・規模・予測
• レポートコード：MRC-IM30008 ▷ お問い合わせ（見積依頼・ご注文・質問）